Table 4.
Year | p-value | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Antibiotics/Strains (n) | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 (01–06) | |
20 | 18 | 7 | 13 | 12 | 5 | 14 | 10 | 9 | – | |
Piperacillin/ tazobactam | 8 (40) | 9 (50) | 3 (42.9) | 7 (53.8) | 6 (50) | 3 (60) | 13 (92.9) | 5 (50) | 2 (22.2) |
p = 0.311 *p = 0.001 |
Ceftazidime | 10 (50) | 7 (38.9) | 3 (42.9) | 8 (61.5) | 7 (58.3) | 3 (60) | 13 (92.9) | 6 (60) | 3 (33.3) |
p = 0.335 *p = 0.0049 |
Cefepime | 13 (65) | 9 (50) | 3 (42.9) | 5 (38.5) | 7 (58.3) | 3 (60) | 14 (100) | 6 (60) | 3 (33.3) |
p = 0.225 *p = 0.0008 |
Imipenem | 11 (55) | 7 (38.9) | 2 (28.6) | 7 (53.8) | 7 (58.3) | 1 (20) | 11 (78.6) | 7 (70) | 2 (22.2) |
p = 0.129 *p = 0.0335 |
Meropenem | 11 (55) | 9 (50) | 2 (28.6) | 7 (53.5) | 8 (66.7) | 1 (20) | 11 (78.6) | 6 (60) | 2 (22.2) |
p = 0.1296 *p = 0.0335 |
Amikacin | 11 (55) | 13(2.7) | 6 (85.7) | 8 (61.5) | 10 (83.3) | 4 (80) | 14 (100) | 7 (70) | 3 (33.3) |
p = 0.427 *p = 0.008 |
Gentamicin | 11 (55) | 9 (50) | 5 (71.4) | 4 (30.8) | 8 (66.7) | 2 (40) | 14 (100) | 7 (70) | 3 (33.3) |
p = 0.427 *p = 0.0008 |
Ciprofloxacin | 9 (45) | 6 (33.3) | 4 (57.1) | 4 (30.8) | 7 (58.3) | 2 (40) | 14 (100) | 6 (60) | 3 (33.3) |
p = 0.4118 *p = 0.0008 |
Colistin | 8 (100) | 10 (100) | 3 (100) | 4 (100) | 5 (100) | 2 (100) | – | 3 (100) | 9 (100) |
Notes: p was calculated for the correlation of data 2011 vs. 2019; * p value for 2017 vs. 2019 Abbreviation: n number of P.aeruginosa strains